BioAsia 2024 to Spotlight Micro, Small, and Medium Enterprises (MSMEs)

Hyderabad, 8th February 2024: BioAsia, Asia’s premier life sciences and Health Tech forum, is proud to announce its partnership with the Ministry of Micro, Small, and Medium Enterprises (MSME), Government of India, for the upcoming 21st edition of the event. Scheduled to take place from February 26 to 28, 2024, in Hyderabad, BioAsia 2024 promises to be a pivotal platform for fostering growth and innovation within the MSME sector.

 The collaboration with the Ministry of MSME underscores BioAsia’s commitment, in line with the Government’s vision, to promoting the growth and development of small and medium-sized enterprises, which play a crucial role in India’s burgeoning life sciences industry. With a dedicated MSME Pavilion featuring leading companies from the sector, BioAsia 2024 offers a unique opportunity for MSMEs to forge key partnerships, expand their businesses, and showcase India’s prowess in the global life sciences arena. Through the Procurement & Market Support (PMS) – Market Access Initiatives of Development and Facilitation Office (DFO), the cost of participation for MSMEs are being subsidized upto 100%.

 Expressing his enthusiasm, Mr. Sridhar Babu, Hon’ble Minister for Industries and Information Technology, Telangana, stated, “The new government in Telangana is dedicated to fostering the growth of MSMEs as the driving force of our economy. BioAsia 2024 will provide a platform for MSMEs to thrive, innovate, and contribute to the advancement of the life sciences sector. Further, I am optimistic that this collaborative endeavour will facilitate the enhancement of technical acumen, bolster infrastructure, and optimize the utilization of shared resources”.

 Mr. Jayesh Ranjan, IAS, Principal Secretary of the Industries & Commerce Department, Government of Telangana, remarked, “Over the preceding two decades, we have observed the participation of numerous global and local players within the healthcare and life science realm as contributors to BioAsia. MSMEs have stood as an indispensable component of BioAsia’s landscape over time, and we take great pleasure i perpetuating our affiliation with the Ministry of Micro, Small, and Medium Enterprises (MSME), Government of India”.

 Mr. D. Chandra Sekhar, Additional Development Commissioner, Development and Facilitation Office (DFO), Hyderabad, articulated, “21st edition of BioAsia, themed ‘Transforming Life Sciences with Data and AI’, is poised to propel the growth prospects for MSME units in India, harnessing its catalyzing investments and global openings within the life sciences domain. Through our engagement and involvement in BioAsia 2024, we anticipate that MSME stakeholders will derive substantial advantages from its elevated prominence within the global healthcare industries.”

 “BioAsia has a legacy of bringing together industry leaders, innovators, and policymakers to drive meaningful change in the healthcare sector. With the inclusion of MSMEs as a focal point, BioAsia 2024 will further strengthen our collective efforts to democratize healthcare and foster innovation for the benefit of society,” said Mr. Shakthi Nagappan, Director (Life Sciences) and CEO (BioAsia).

 Over the years, the event has immensely benefitted from its participant history including the likes of several Nobel Prize winners, Lasker Awardees and eminent industry leaders like Mr. Bill Gates (Chair, Gates Foundation), Mr. Satya Nadella (CEO of Microsoft), Mr. Alex Gorsky (Executive Chairman, Johnson & Johnson), Dr. Vas Narasimhan (CEO, Novartis), Mr. Geoff Martha (Chairman & CEO, Medtronic), besides hosting the Country Ministers and Delegates from Asia, America, Africa, and Europe. Being the first edition post-pandemic, BioAsia 2023 was extremely successful with the virtual participation of more than 3000 global participants from over 50+ Countries.